Chapter 6 Interpreting the Proteome and Peptidome in Transplantation

Advances in Clinical Chemistry

Volumn 47, Issue , 2009, Pages 139-169

  Sigdel, Tara K ^a   Klassen, R Bryan ^a   Sarwal, Minnie M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; PROTEOME;

GENETICS; HUMAN; REVIEW; TRANSPLANTATION;

HUMANS; PEPTIDES; PROTEOME; TRANSPLANTATION;

EID: 67651245173     PISSN: 00652423     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2423(09)47006-9     Document Type: Review

References (120)

1. Butte A.J. Medicine. The ultimate model organism. Science 320 5874 (2008) 325-327
2. Gerszten R.E., and Wang T.J. The search for new cardiovascular biomarkers. Nature 451 7181 (2008) 949-952
3. Sarwal M.M., Yorgin P.D., Alexander S., Millan M.T., Belson A., Belanger N., et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 72 1 (2001) 13-21
4. Corey H.E., Greenstein S.M., Tellis V., Schechner R., Greifer I., and Bennett B. Renal allograft rejection in children and young adults: the Banff classification. Pediatr. Nephrol. 9 3 (1995) 309-312
5. Gulanikar A.C., MacDonald A.S., Sungurtekin U., and Belitsky P. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. Transplantation 53 2 (1992) 323-328
6. Hariharan S., Johnson C.P., Bresnahan B.A., Taranto S.E., McIntosh M.J., and Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N. Engl. J. Med. 342 9 (2000) 605-612
7. Schena M., Shalon D., Davis R.W., and Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 5235 (1995) 467-470
8. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250 10 (1975) 4007-4021
9. Lilley K.S., and Friedman D.B. All about DIGE: quantification technology for differential-display 2D-gel proteomics. Expert Rev. Proteomics 1 4 (2004) 401-409
10. Rozanas C.R., and Loyland S.M. Capabilities using 2-D DIGE in proteomics research: the new gold standard for 2-D gel electrophoresis. Methods Mol. Biol. 441 (2008) 1-18
11. Unlu M., Morgan M.E., and Minden J.S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18 11 (1997) 2071-2077
12. Wang L.Y., Chakraborty A., and Comaniciu D. Molecular diagnosis and biomarker identification on SELDI proteomics data by ADTBoost method. Conf. Proc. IEEE Eng. Med. Biol. Soc. 5 (2005) 4771-4774
13. Seibert V., Ebert M.P., and Buschmann T. Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery. Brief Funct. Genomic Proteomic 4 1 (2005) 16-26
14. Liu Z., Tian Y., Wang B., Yan Z., Qian D., Ding S., et al. Serum proteomics with SELDI-TOF-MS in congenital human cytomegalovirus hepatitis. J. Med. Virol. 79 10 (2007) 1500-1505
15. Issaq H.J., Veenstra T.D., Conrads T.P., and Felschow D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 292 3 (2002) 587-592
16. Issaq H.J., Conrads T.P., Prieto D.A., Tirumalai R., and Veenstra T.D. SELDI-TOF MS for diagnostic proteomics. Anal. Chem. 75 7 (2003) 148A-155A
17. Hu Y., Zhang S., Yu J., Liu J., and Zheng S. SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer. Breast 14 4 (2005) 250-255
18. El Essawy B., Otu H.H., Choy B., Zheng X.X., Libermann T.A., and Strom T.B. Proteomic analysis of the allograft response. Transplantation 82 2 (2006) 267-274
19. Schaub S., Wilkins J.A., Antonovici M., Krokhin O., Weiler T., Rush D., et al. Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am. J. Transplant 5 4 Pt 1 (2005) 729-738
20. Schaub S., Wilkins J., Weiler T., Sangster K., Rush D., and Nickerson P. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int. 65 1 (2004) 323-332
21. Schaub S., Wilkins J.A., Rush D., and Nickerson P. Developing a tool for noninvasive monitoring of renal allografts. Expert Rev. Proteomics 3 5 (2006) 497-509
22. Oetting W.S., Rogers T.B., Krick T.P., Matas A.J., and Ibrahim H.N. Urinary beta2-microglobulin is associated with acute renal allograft rejection. Am. J. Kidney Dis. 47 5 (2006) 898-904
23. Bogdanov B., and Smith R.D. Proteomics by FTICR mass spectrometry: top down and bottom up. Mass Spectrom. Rev. 24 2 (2005) 168-200
24. Wolters D.A., Washburn M.P., and Yates III J.R. An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 73 23 (2001) 5683-5690
25. Tammen H., Peck A., Budde P., and Zucht H.D. Peptidomics analysis of human blood specimens for biomarker discovery. Expert Rev. Mol. Diagn. 7 5 (2007) 605-613
26. Li B., Predel R., Neupert S., Hauser F., Tanaka Y., Cazzamali G., et al. Genomics, transcriptomics, and peptidomics of neuropeptides and protein hormones in the red flour beetle Tribolium castaneum. Genome Res. 18 1 (2008) 113-122
27. Predel R., Russell W.K., Russell D.H., Lopez J., Esquivel J., and Nachman R.J. Comparative peptidomics of four related hemipteran species: pyrokinins, myosuppressin, corazonin, adipokinetic hormone, sNPF, and periviscerokinins. Peptides 29 2 (2008) 162-167
28. Villanueva J., Shaffer D.R., Philip J., Chaparro C.A., Erdjument-Bromage H., Olshen A.B., et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J. Clin. Invest. 116 1 (2006) 271-284
29. Jurgens M., Appel A., Heine G., Neitz S., Menzel C., Tammen H., et al. Towards characterization of the human urinary peptidome. Comb. Chem. High Throughput Screen 8 8 (2005) 757-765
30. Romanova E.V., Rubakhin S.S., and Sweedler J.V. One-step sampling, extraction, and storage protocol for peptidomics using dihydroxybenzoic acid. Anal. Chem. 80 9 (2008) 3379-3386
31. Herrero M., Ibanez E., and Cifuentes A. Capillary electrophoresis-electrospray-mass spectrometry in peptide analysis and peptidomics. Electrophoresis 29 10 (2008) 2148-2160
32. Jacobs J.M., Adkins J.N., Qian W.J., Liu T., Shen Y., Camp II D.G., et al. Utilizing human blood plasma for proteomic biomarker discovery. J. Proteome Res. 4 4 (2005) 1073-1085
33. Kanie Y., Enomoto A., Goto S., and Kanie O. Comparative RP-HPLC for rapid identification of glycopeptides and application in off-line LC-MALDI-MS analysis. Carbohydr. Res. 343 4 (2008) 758-768
34. Stodulkova E., Novak P., Deininger S.O., Man P., Capkova J., Kavan D., et al. LC MALDI-TOF MS/MS and LC ESI FTMS analyses of HLA-B27 associated peptides isolated from peripheral blood cells. Immunol. Lett. 116 1 (2008) 79-85
35. Theodorescu D., Wittke S., Ross M.M., Walden M., Conaway M., Just I., et al. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol. 7 3 (2006) 230-240
36. Decramer S., Wittke S., Mischak H., Zurbig P., Walden M., Bouissou F., et al. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat. Med. 12 4 (2006) 398-400
37. Zougman A., Pilch B., Podtelejnikov A., Kiehntopf M., Schnabel C., Kumar C., et al. Integrated analysis of the cerebrospinal fluid peptidome and proteome. J. Proteome Res. 7 1 (2008) 386-399
38. Hu S., Yu T., Xie Y., Yang Y., Li Y., Zhou X., et al. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics 4 2 (2007) 55-64
39. Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell Proteomics 1 5 (2002) 376-386
40. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., and Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17 10 (1999) 994-999
41. Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics 3 12 (2004) 1154-1169
42. Griffiths S.D., Burthem J., Unwin R.D., Holyoake T.L., Melo J.V., Lucas G.S., et al. The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia. Mol. Biotechnol. 36 2 (2007) 81-89
43. Abdi F., Quinn J.F., Jankovic J., McIntosh M., Leverenz J.B., Peskind E., et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J. Alzheimers Dis. 9 3 (2006) 293-348
44. Mirgorodskaya O.A., Kozmin Y.P., Titov M.I., Korner R., Sonksen C.P., and Roepstorff P. Quantitation of peptides and proteins by matrix-assisted laser desorption/ionization mass spectrometry using (18)O-labeled internal standards. Rapid Commun. Mass Spectrom. 14 14 (2000) 1226-1232
45. Liao H., Wu J., Kuhn E., Chin W., Chang B., Jones M.D., et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum. 50 12 (2004) 3792-3803
46. Traum A.Z., Wells M.P., Aivado M., Libermann T.A., Ramoni M.F., and Schachter A.D. SELDI-TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions. Proteomics 6 5 (2006) 1676-1680
47. Canas B., Pineiro C., Calvo E., Lopez-Ferrer D., and Gallardo J.M. Trends in sample preparation for classical and second generation proteomics. J. Chromatogr. A 1153 1-2 (2007) 235-258
48. Thongboonkerd V., Chutipongtanate S., and Kanlaya R. Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability. J. Proteome Res. 5 1 (2006) 183-191
49. Sigdel T.K., Cilliers R., Gursahaney P.R., and Crowder M.W. Fractionation of soluble proteins in Escherichia coli using DEAE-, SP-, and phenyl sepharose chromatographies. J. Biomol. Tech. 15 3 (2004) 199-207
50. Sigdel T.K., Lau K., Schilling J., and Sarwal M.M. Optimizing protein recovery for urinary proteomics, a tool to monitor renal transplantation. Clin. Transplant. 22 5 (2008) 617-623
51. Thongboonkerd V., and Malasit P. Renal and urinary proteomics: current applications and challenges. Proteomics 5 4 (2005) 1033-1042
52. Adachi J., Kumar C., Zhang Y., Olsen J.V., and Mann M. The human urinary proteome contains more than 1500 proteins including a large proportion of membranes proteins. Genome Biol. 7 9 (2006) R80
53. Ye B., Skates S., Mok S.C., Horick N.K., Rosenberg H.F., Vitonis A., et al. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clin. Cancer Res. 12 2 (2006) 432-441
54. Marshall T., and Williams K.M. Total protein determination in urine: elimination of a differential response between the coomassie blue and pyrogallol red protein dye-binding assays. Clin. Chem. 46 3 (2000) 392-398
55. Park M.R., Wang E.H., Jin D.C., Cha J.H., Lee K.H., Yang C.W., et al. Establishment of a 2-D human urinary proteomic map in IgA nephropathy. Proteomics 6 3 (2006) 1066-1076
56. Sharma K., Lee S., Han S., Lee S., Francos B., McCue P., et al. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 5 10 (2005) 2648-2655
57. Bueler M.R., Wiederkehr F., and Vonderschmitt D.J. Electrophoretic, chromatographic and immunological studies of human urinary proteins. Electrophoresis 16 1 (1995) 124-134
58. Marshall T., and Williams K. Two-dimensional electrophoresis of human urinary proteins following concentration by dye precipitation. Electrophoresis 17 7 (1996) 1265-1272
59. Castagna A., Cecconi D., Sennels L., Rappsilber J., Guerrier L., Fortis F., et al. Exploring the hidden human urinary proteome via ligand library beads. J. Proteome Res. 4 6 (2005) 1917-1930
60. Zerefos P.G., Vougas K., Dimitraki P., Kossida S., Petrolekas A., Stravodimos K., et al. Characterization of the human urine proteome by preparative electrophoresis in combination with 2-DE. Proteomics 6 15 (2006) 4346-4355
61. Li L., Ying L., Naesens M., Xiao W., Sigdel T., Hsieh S., et al. Interference of globin genes with biomarker discovery for allograft rejection in peripheral blood samples. Physiol. Genomics 32 2 (2008) 190-197
62. Anderson N.L., and Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteomics 1 11 (2002) 845-867
63. Liu T., Qian W.J., Mottaz H.M., Gritsenko M.A., Norbeck A.D., Moore R.J., et al. Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry. Mol. Cell Proteomics 5 11 (2006) 2167-2174
64. Qian W.J., Jacobs J.M., Liu T., Camp II D.G., and Smith R.D. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol. Cell Proteomics 5 10 (2006) 1727-1744
65. Brand J., Haslberger T., Zolg W., Pestlin G., and Palme S. Depletion efficiency and recovery of trace markers from a multiparameter immunodepletion column. Proteomics 6 11 (2006) 3236-3242
66. Zolotarjova N., Mrozinski P., Chen H., and Martosella J. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum. J. Chromatogr. A 1189 1-2 (2008) 332-338
67. Fountoulakis M., Juranville J.F., Jiang L., Avila D., Roder D., Jakob P., et al. Depletion of the high-abundance plasma proteins. Amino Acids 27 3-4 (2004) 249-259
68. Yang Z., and Hancock W.S. Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column. J. Chromatogr. A 1053 1-2 (2004) 79-88
69. Heo S.H., Lee S.J., Ryoo H.M., Park J.Y., and Cho J.Y. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. Proteomics 7 23 (2007) 4292-4302
70. Yang Z., Harris L.E., Palmer-Toy D.E., and Hancock W.S. Multilectin affinity chromatography for characterization of multiple glycoprotein biomarker candidates in serum from breast cancer patients. Clin. Chem. 52 10 (2006) 1897-1905
71. Pisitkun T., Shen R.F., and Knepper M.A. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA 101 36 (2004) 13368-13373
72. Thongboonkerd V., Semangoen T., and Chutipongtanate S. Enrichment of the basic/cationic urinary proteome using ion exchange chromatography and batch adsorption. J. Proteome Res. 6 3 (2007) 1209-1214
73. Alban A., Andrew David S.O., Stephen Olu Bjorkesten L., Lennart Andersson C., Christian Sloge E., Erik Lewis S., et al. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 3 1 (2003) 36-44
74. Washburn M.P., Wolters D., and Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19 3 (2001) 242-247
75. Heller M., Michel P.E., Morier P., Crettaz D., Wenz C., Tissot J.D., et al. Two-stage Off-Gel isoelectric focusing: protein followed by peptide fractionation and application to proteome analysis of human plasma. Electrophoresis 26 6 (2005) 1174-1188
76. Weber G., and Wildgruber R. Free-flow electrophoresis system for proteomics applications. Methods Mol. Biol. 384 (2008) 703-716
77. Liu T., Qian W.J., Camp II D.G., and Smith R.D. The use of a quantitative cysteinyl-peptide enrichment technology for high-throughput quantitative proteomics. Methods Mol. Biol. 359 (2007) 107-124
78. Thaysen-Andersen M., Thogersen I.B., Lademann U., Offenberg H., Giessing A.M., Enghild J.J., et al. Investigating the biomarker potential of glycoproteins using comparative glycoprofiling-Application to tissue inhibitor of metalloproteinases-1. Biochim. Biophys. Acta 1784 3 (2008) 455-463
79. Righetti P.G., Boschetti E., Lomas L., and Citterio A. Protein equalizer technology: the quest for a "democratic proteome". Proteomics 6 14 (2006) 3980-3992
80. Waikar S.S., and Bonventre J.V. Biomarkers for the diagnosis of acute kidney injury. Curr. Opin. Nephrol. Hypertens. 16 6 (2007) 557-564
81. Brouard S., Mansfield E., Braud C., Li L., Giral M., Hsieh S.C., et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc. Natl. Acad. Sci. USA 104 39 (2007) 15448-15453
82. Sarwal M., and Pascual J. Immunosuppression minimization in pediatric transplantation. Am. J. Transplant. 7 10 (2007) 2227-2235
83. Sarwal M., Chua M.S., Kambham N., Hsieh S.C., Satterwhite T., Masek M., et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl. J. Med. 349 2 (2003) 125-138
84. Morgun A., Shulzhenko N., Perez-Diez A., Diniz R.V., Sanson G.F., Almeida D.R., et al. Molecular profiling improves diagnoses of rejection and infection in transplanted organs. Circ. Res. 98 12 (2006) e74-e83
85. Schaub S., Rush D., Wilkins J., Gibson I.W., Weiler T., Sangster K., et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J. Am. Soc. Nephrol. 15 1 (2004) 219-227
86. O'Riordan E., Orlova T.N., Mei J.J., Butt K., Chander P.M., Rahman S., et al. Bioinformatic analysis of the urine proteome of acute allograft rejection. J. Am. Soc. Nephrol. 15 12 (2004) 3240-3248
87. Vidal B.C., Bonventre J.V., and IHH S. Towards the application of proteomics in renal disease diagnosis. Clin. Sci. (Lond.) 109 5 (2005) 421-430
88. Gonzalez-Buitrago J.M., Ferreira L., and Lorenzo I. Urinary proteomics. Clin. Chim. Acta 375 1-2 (2007) 49-56
89. Oh J., Pyo J.H., Jo E.H., Hwang S.I., Kang S.C., Jung J.H., et al. Establishment of a near-standard two-dimensional human urine proteomic map. Proteomics 4 11 (2004) 3485-3497
90. Holly M.K., Dear J.W., Hu X., Schechter A.N., Gladwin M.T., Hewitt S.M., et al. Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. Kidney Int. 70 3 (2006) 496-506
91. Rai A.J., and Chan D.W. Cancer proteomics: serum diagnostics for tumor marker discovery. Ann. N. Y. Acad. Sci. 1022 (2004) 286-294
92. Hoorn E.J., Pisitkun T., Zietse R., Gross P., Frokiaer J., Wang N.S., et al. Prospects for urinary proteomics: exosomes as a source of urinary biomarkers. Nephrology (Carlton) 10 3 (2005) 283-290
93. Pisitkun T., Johnstone R., and Knepper M.A. Discovery of urinary biomarkers. Mol. Cell Proteomics 5 10 (2006) 1760-1771
94. Clarke W., Silverman B.C., Zhang Z., Chan D.W., Klein A.S., and Molmenti E.P. Characterization of renal allograft rejection by urinary proteomic analysis. Ann. Surg. 237 5 (2003) 660-664
95. O'Riordan E., Orlova T.N., Podust V.N., Chander P.N., Yanagi S., Nakazato M., et al. Characterization of urinary peptide biomarkers of acute rejection in renal allografts. Am. J. Transplant 7 4 (2007) 930-940
96. Yasui H., Yoshimura N., Kobayashi Y., Ochiai S., Matsuda T., Takamatsu T., et al. Microstructural changes of bile canaliculi in canine liver: the effect of cold ischemia-reperfusion in orthotopic liver transplantation. Transplant. Proc. 30 7 (1998) 3754-3757
97. Emadali A., Muscatelli-Groux B., Delom F., Jenna S., Boismenu D., Sacks D.B., et al. Proteomic analysis of ischemia-reperfusion injury upon human liver transplantation reveals the protective role of IQGAP1. Mol. Cell Proteomics 5 7 (2006) 1300-1313
98. Avellini C., Baccarani U., Trevisan G., Cesaratto L., Vascotto C., D'Aurizio F., et al. Redox proteomics and immunohistology to study molecular events during ischemia-reperfusion in human liver. Transplant. Proc. 39 6 (2007) 1755-1760
99. Hsu L.W., Goto S., Nakano T., Lai C.Y., Lin Y.C., Kao Y.H., et al. Immunosuppressive activity of serum taken from a liver transplant recipient after withdrawal of immunosuppressants. Transpl. Immunol. 17 2 (2007) 137-146
100. Aiello F.B., Calabrese F., Rigotti P., Furian L., Marino S., Cusinato R., et al. Acute rejection and graft survival in renal transplanted patients with viral diseases. Mod. Pathol. 17 2 (2004) 189-196
101. Itano A.A., and Jenkins M.K. Antigen presentation to naive CD4 T cells in the lymph node. Nat. Immunol. 4 8 (2003) 733-739
102. Dos Remedios C.G., Liew C.C., Allen P.D., Winslow R.L., Van Eyk J.E., and Dunn M.J. Genomics, proteomics and bioinformatics of human heart failure. J. Muscle Res. Cell Motil. 24 4-6 (2003) 251-260
103. Corbett J.M., Why H.J., Wheeler C.H., Richardson P.J., Archard L.C., Yacoub M.H., et al. Cardiac protein abnormalities in dilated cardiomyopathy detected by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 19 11 (1998) 2031-2042
104. Meirovich Y.F., Veinot J.P., de Bold M.L., Haddad H., Davies R.A., Masters R.G., et al. Relationship between natriuretic peptides and inflammation: proteomic evidence obtained during acute cellular cardiac allograft rejection in humans. J. Heart Lung Transplant. 27 1 (2008) 31-37
105. Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J. Heart Lung Transplant. 23 5 Suppl. (2004) S187-S193
106. De Souza A.I., Wait R., Mitchell A.G., Banner N.R., Dunn M.J., and Rose M.L. Heat shock protein 27 is associated with freedom from graft vasculopathy after human cardiac transplantation. Circ. Res. 97 2 (2005) 192-198
107. Tabbara I.A., Zimmerman K., Morgan C., and Nahleh Z. Allogeneic hematopoietic stem cell transplantation: complications and results. Arch. Intern Med. 162 14 (2002) 1558-1566
108. Kaiser T., Kamal H., Rank A., Kolb H.J., Holler E., Ganser A., et al. Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood 104 2 (2004) 340-349
109. Srinivasan R., Daniels J., Fusaro V., Lundqvist A., Killian J.K., Geho D., et al. Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis. Exp. Hematol. 34 6 (2006) 796-801
110. Hueber W., Tomooka B.H., Zhao X., Kidd B.A., Drijfhout J.W., Fries J.F., et al. Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines. Ann. Rheum. Dis. 66 6 (2007) 712-719
111. Oberg A.L., Mahoney D.W., Eckel-Passow J.E., Malone C.J., Wolfinger R.D., Hill E.G., et al. Statistical analysis of relative labeled mass spectrometry data from complex samples using ANOVA. J. Proteome Res. 7 1 (2008) 225-233
112. Roxas B.A., and Li Q. Significance analysis of microarray for relative quantitation of LC/MS data in proteomics. BMC Bioinformatics 9 1 (2008) 187
113. Dudley J., and Butte A.J. Enabling integrative genomic analysis of high-impact human diseases through text mining. Pac. Symp. Biocomput. 13 (2008) 580-591
114. Basic-Jukic N., Juric I., Kes P., Bubic-Filipi L., Brunetta B., and Pasini J. [Arterial hypertension in renal transplant recipients]. Acta Med. Croatica 61 2 (2007) 171-176
115. Hancock W.S., Wu S.L., Stanley R.R., and Gombocz E.A. Publishing large proteome datasets: scientific policy meets emerging technologies. Trends Biotechnol. 20 12 Suppl. (2002) S39-S44
116. Zucht H.D., Lamerz J., Khamenia V., Schiller C., Appel A., Tammen H., et al. Datamining methodology for LC-MALDI-MS based peptide profiling. Comb. Chem. High Throughput Screen 8 8 (2005) 717-723
117. Schrader M., and Selle H. The process chain for peptidomic biomarker discovery. Dis. Markers 22 1-2 (2006) 27-37
118. Taylor C.F., Paton N.W., Lilley K.S., Binz P.A., Julian Jr. R.K., Jones A.R., et al. The minimum information about a proteomics experiment (MIAPE). Nat. Biotechnol. 25 8 (2007) 887-893
119. Johnson T., Bergquist J., Ekman R., Nordhoff E., Schurenberg M., Kloppel K.D., et al. A CE-MALDI interface based on the use of prestructured sample supports. Anal. Chem. 73 8 (2001) 1670-1675
120. Floyd P.D., Li L., Moroz T.P., and Sweedler J.V. Characterization of peptides from Aplysia using microbore liquid chromatography with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry guided purification. J. Chromatogr. A 830 1 (1999) 105-113